AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,768,000 | -59.9% | 306,872 | -52.3% | 1.38% | -73.5% |
| Q4 2017 | $24,342,000 | +26.4% | 643,626 | -17.1% | 5.21% | +34.0% |
| Q3 2017 | $19,257,000 | +20.6% | 776,813 | 0.0% | 3.89% | -3.2% |
| Q2 2017 | $15,971,000 | -3.7% | 776,813 | +1.8% | 4.02% | -17.5% |
| Q1 2017 | $16,580,000 | +6.3% | 763,009 | 0.0% | 4.88% | -5.2% |
| Q4 2016 | $15,604,000 | +36.3% | 763,009 | 0.0% | 5.14% | +44.2% |
| Q3 2016 | $11,445,000 | +38.6% | 763,009 | 0.0% | 3.57% | +58.2% |
| Q2 2016 | $8,256,000 | – | 763,009 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |